They also investigated the prognostic role of PROX1 in 327 gastric cancer patients by immunohistochemistry, finding that the survival of patients with PROX1-positive tumors was significantly worse than for those with PROX1-negative tumors. The gene discussed is PROX1; the disease is gastric cancer.